Table 1 Baseline characteristics and optical coherence tomography parameters of HBOT group and control group.
Characteristics | HBOT group (nā=ā29) | Control group (nā=ā21) | P value* |
|---|---|---|---|
Age (years) | 65.69ā±ā15.22 | 69.86ā±ā11.01 | 0.536 |
Sex (male/female) | 17/12 | 14/7 | 0.719 |
Medical History | |||
Ā Diabetic mellitus | 10 (34.38%) | 7 (33.33%) | 0.557 |
Ā Hypertension | 17 (65.38%) | 13 (61.9%) | 0.788 |
Ā Hyperlipidemia | 8 (27.59%) | 6 (20.69%) | 0.745 |
Clinical characteristics at presentation | |||
Ā Baseline VA (logMAR) | 2.03ā±ā0.74 | 2.1ā±ā0.7 | 0.737 |
Ā Duration of symptoms (hours) | 11.34ā±ā4.86 | 15.09ā±ā5.78 | 0.357 |
Ā Baseline CFT (μm) | 347.28ā±ā86.59 | 382.55ā±ā91.44 | 0.174 |
Ā Baseline CCT (μm) | 220.38ā±ā53.95 | 228.77ā±ā41.33 | 0.487 |
Ā Baseline ORLT (μm) | 193.07ā±ā36.78 | 211.36ā±ā52.46 | 0.343 |
Ā Baseline IRLT (μm) | 176.57ā±ā53.67 | 184.18ā±ā61.89 | 0.762 |